Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03581877 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Completed to Active, Not Recruiting Completion date: Mar 19, 2023 to Mar 19, 2025v11 Show 1 more changeShow less
    • Completion date: Mar 19, 2023 to Mar 19, 2025
  2. Trial status: Active, Not Recruiting to Completed Primary completion date changed from estimate of Dec 2022 to Mar 19, 2023 · Study completion date changed from estimate of Mar 2023 to Mar 19, 2023v10 Show 2 more changesShow less
    • Primary completion date changed from estimate of Dec 2022 to Mar 19, 2023
    • Study completion date changed from estimate of Mar 2023 to Mar 19, 2023
  3. Primary completion date: Dec 2021 to Dec 2022 Trial status: Recruiting to Active, Not Recruiting · Enrollment target: estimated 158 to confirmed 31 · Completion date: Dec 2022 to Mar 2023 · 1 morev9 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 158 to confirmed 31
    • Completion date: Dec 2022 to Mar 2023
    • Site details revised at 2 of 2 sites
  4. 4 versions Re-verified since Jan 30, 2019, no change to tracked fieldsv5-v8
  5. Trial status: Not Yet Recruiting to Recruiting Start date: Dec 1, 2018 to Jan 28, 2019 · Study sites: 1 to 2 · Study title shortened, about 2 wordsv4 Show 3 more changesShow less
    • Start date: Dec 1, 2018 to Jan 28, 2019
    • Study sites: 1 to 2
    • Study title shortened, about 2 words

    See this version in full on ClinicalTrials.gov ↗

Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Jul 2018 to Dec 1, 2018 Enrollment target: 136 to 158 · Primary completion date: Jul 2021 to Dec 2021 · Completion date: Jul 2022 to Dec 2022v3 Show 3 more changesShow less
    • Enrollment target: 136 to 158
    • Primary completion date: Jul 2021 to Dec 2021
    • Completion date: Jul 2022 to Dec 2022
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Northwell Health
133 trials monitored
See 10 trials at risk
Hypertension
1,795 trials monitored
See 85 trials at risk
To determine whether peripheral low dose systemic thrombolysis (PLST) is non-inferior to catheter directed acoustic pulse thrombolysis (ACDT) in improving RV function and reducing pulmonary artery pressures in submassive pulmonary embolism (PE)
Trial Details
NCT Number NCT03581877
Lead Sponsor Northwell Health
Conditions Pulmonary Embolism, Pulmonary Hypertension, Thromboembolism, Right Ventricular Dysfunction
Enrollment 31 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov